ArticleProstate cancer and prostatic diseases2019

Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.

Chang Wook Jeong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.